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Role of Cytokines and Major Histocompatibility Complex Restriction in
Mouse Resistance to Infection with a Natural Recombinant
Strain (Type I-III) of Toxoplasma gondii
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Herein we characterized various genetic markers and the biological behavior of a natural recombinant strain
of Toxoplasma gondii (P-Br). From nine genetic markers analyzed, three (B1, ROP1, and SAG1) and three
(cS10-A6, GRA6, and SAG3) markers belong to parasites from the type I and type III lineages, respectively. The
SAG2 and L363 loci were shown to be type I-III chimera alleles. The cB2l-4 microsatellite marker showed a
unique haplotype. The P-Br strain presented low virulence in the acute phase of infection and was cystogenic
during the chronic infection. The interleukin 12/gamma interferon axis and inducible nitric oxide synthase
were main determinants of resistance during the acute infection with the P-Br strain. As opposed to infection
with the type II strain of T. gondii (ME-49), peroral infection with the P-Br strain led only to a light inflam-
matory infiltrate and no major lesions in the intestine of the C57BL/6 mice. In addition, the BALB/c (resistant
to ME-49) and C57BL/6 (susceptible to ME-49) mice were shown, respectively, to be more susceptible and more
resistant to cyst formation and toxoplasmic encephalitis when infected with the P-Br strain. Further, the
C57BL/KsJ and DBA2/J congenic strains containing major histocompatibility complex (MHC) haplotype “d”
were more resistant than the parental strains (C57BL/6 and DBA1/J), when infected with the ME-49 but not
with the P-Br strain. Together, our results indicate that resistance to cyst formation and toxoplasmic enceph-
alitis induced during infection with P-Br is not primarily controlled by the MHC haplotype d, as previously
reported for type II strains of T. gondii.
Toxoplasma gondii is a protozoan parasite, distributed world-
wide, that has been known to infect more than 30 species of
birds and 300 species of mammals, including humans (9). It is
believed that one-third of the world population is chronically
infected with this parasite (12). Toxoplasmosis is common and
establishes itself as a lifelong chronic infection after consump-
tion of undercooked meat harboring tissue cysts or from acci-
dental ingestion of oocysts shed in cat feces. In most individ-
uals the infection is asymptomatic, whereas severe pathology
and lethality due to toxoplasmosis are a common finding in
congenitally infected or immunodeficient individuals (8). In
addition, toxoplasmosis is one of the most common causes of
infectious uveitis in both imunocompetent and imunocompro-
mised persons (24). In fact, ocular uveitis is found in 2 to 20%
of the T. gondii-infected human population, depending on the
geographic area (18, 38). Variation in the clinical presentation
and severity of disease in susceptible persons has been attrib-
uted to several factors, including the genetic heterogeneity of
the host and the genotype of the infective parasite (24, 27, 42).
Some aspects of host resistance to pathogenesis and lethality
observed during infection with T. gondii have been elucidated,
whereas the influence of parasite strains on outcome of disease
during toxoplasmosis is largely unknown. Nevertheless, recent
studies show that the structure of the T. gondii population is
clonal, since most strains fall into one of the three categories of
lineage denominated type I, type II and type III (27, 42). The
type I lineage was shown to exclusively contain those strains
that are highly virulent, whereas type II and type III strains
display lower virulence in mice. A small percentage of strains
are recombinant between two of three parasite lineages and
vary in terms of their virulence phenotype in mice (20). Mo-
lecular clinical epidemiology studies have shown an association
of certain parasite lineages and disease outcome in humans.
For instance, most cases of reactivation of T. gondii infection in
AIDS patients is associated with type II strains (27). In con-
trast, type I or recombinant type I-III strains are more often
found in patients with ocular toxoplasmosis (22).
Different studies performed with mice show the important
role of cytokines, such as IL-12, TNF-, and IFN-, and gen-
eration of RNI as mediators of host resistance to early T.
gondii infection (1, 7). Thus, animals deficient in IL-12, IFN-,
and iNOS or those treated with neutralizing antibodies, anti-
cytokines, or specific inhibitors of iNOS are highly susceptible
to infection with T. gondii (14, 15, 23, 41, 44, 46). Acquired
immunity to T. gondii is associated with a Th1-type response
(14, 17). During chronic infection, neutralization of either
IFN- or TNF- results in the reactivation of disease and the
development of TE (13, 14, 16, 45, 47). Further, other host
genetic factors, including MHC alleles, are important determi-
nants of host resistance and susceptibility to early infection, as
* Corresponding author. Mailing address: Laboratory of Immunopa-
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well as controlling cyst numbers and encephalitis at later stages
of infection with T. gondii in mice (2, 3, 4, 29, 30, 37). Consistent-
ly, both CD4 T as well as CD8 T lymphocytes are important
components in host resistance to this parasite (4, 14, 17).
In the present study, we characterize a particular recom-
binant (type I-III) strain of T. gondii, named P-Br, which
presents low virulence and is cystogenic in mice. We also de-
termined some immunological components involved in host
resistance to infection with this parasite strain. As previously
shown for other strains of T. gondii, we found that the IL-12/
IFN- axis and iNOS are important components of early re-
sistance to the P-Br strain. More importantly, we demonstrate
here that resistance to cyst formation and TE induced during
infection with P-Br is not primarily controlled by the MHC
haplotype “d,” as previously reported for type II strains of T.
gondii (2, 4). Thus, our results show that the involvement of the
MHC haplotype in host resistance to cyst formation and TE
may also vary according to the lineage of the infective strain of
T. gondii.
MATERIALS AND METHODS
Abbreviations. CNS, central nervous system; IL-12, interleukin 12; INF-,
gamma interferon; iNOS, inducible nitric oxide synthase; KO, knockout; MHC,
major histocompatibility complex; RFLP, restriction fragment length polymor-
phism; RNI, reactive nitrogen intermediates; ROP, rhoptry protein; SAG, sur-
face antigen; TE, toxoplasmic encephalitis; and TNF-, tumor necrosis factor
alpha.
Animals. BALB/c, C3H/He, C57BL/6, DBA1/J, IL-12 KO, IFN- KO, and
iNOs KO mice and the congenic mice (C57BL/KsJ and DBA2/J) were bred as
homozygotes and were kept in the animal house of the Biological Sciences
Institute, Federal University of Minas Gerais. The KO mice were all in the
C57BL/6 background. Mice were maintained in microisolators to minimize in-
fection with environmental pathogens. All animals used for the experiments were
females or males aged 8 weeks, as indicated in the figure legends and tables,
when appropriated.
Parasite strains. The following representative strain types were used for stan-
dardization of PCR assays: strains RH (type I) (40), ME-49 (36), and PTG (32)
(type II), as well as VEG (11) and CTG (39) (type III). ME-49 and P-Br (28)
strains were maintained in Swiss female mice.
DNA isolation. For DNA extraction, 106 tachyzoites were incubated in lysis
buffer (10 mM Tris-HCl [pH 8.0], 0.1 M EDTA, and 0.5% sodium dodecyl
sulfate) at 37°C. After 1 h of incubation, 100 g of proteinase K (Promega
Biosciences, Inc., San Luis Obispo, Calif.)/ml was added to tachyzoites solubi-
lized in lysis buffer, following overnight incubation at 50°C. After inactivation of
the proteinase K, we added phenol:chloroform for 15 min, following centrifuga-
tion for 300 g for 15 min, and the supernatant precipitated with sodium acetate
(3 M) and ethanol. The suspensions were incubated during 1 h at 20°C and was
centrifuged for 15 min at 4°C. The DNA samples were resuspended in ethanol
(70%) and were centrifuged for 15 min at 4°C. The DNA precipitates were
dissolved in milli-Q-treated water and were stored at 20°C.
Genotype analysis. The lineage type was determined by restriction fragment of
amplified SAG1 (27), SAG2 (25), SAG3 (22), B1 (21), ROP1 (26), cB2l-4, cS10-
A6, GRA6, and L363. The mix PCRs consisted of 60 ng of DNA, 0.2 mM
deoxynucleoside triphosphate, 3 l of 10 PCR buffer, 50 mM MgCl2, 1.5 U of
Taq DNA polymerase (Cenbiot, Porto Alegre, Brazil), and 5 pmol of each
primer in a final volume of 30 l. The PCRs were performed in a thermal cycler.
The first step of amplification was 3 min of denaturation at 94°C. This step was
followed by 30 cycles at 94°C for 60 s, and the annealing step temperature for
each pair of primers consisted of 67°C for SAG1, 62°C for SAG2, 65°C for B1,
66°C for ROP1, and 55°C for CB21-4, cS10-A6, GRA6, L363, and SAG3, followed
by incubation at 72°C during 60 s. The final cycle was followed by an extension
step of 10 min at 72°C. Amplification and generation of polymorphic restriction
fragments from each cDNA were performed by using the following primers:
5CAATGTGCACCTGTAGGAAGC 3 and 5CAACGGTAATCACTCA
CGCG 3 for SAG1, producing a fragment 1,183 bp long; 5GAAATGTTTCA
GGTTGCTGC3 and 5AACGTTTCACGAAGGCACAC3 for SAG2, produc-
ing a fragment 1,310 bp long; 5ACCCATCTGCGAAGAAAACG3 and 5AT
TTCGACCAGCGGGAGCAC3 for SAG2, producing a 546-bp fragment; 5C
AACTCTCACCATTCCACCC3 and 5GCGCGTTGTTAGACAAGACA3
for SAG3, producing a 311-bp fragment; 5TGTCTGTCCTATCGCAACG3
and 5ACGGATGCAGTTCCTTTCTG3, for B1, producing a 577-bp frag-
ment; 5CGTGACATATTACTGCACTGACG3 and 5ACCATCTGGAAAC
TCGATCAC3 for ROP1, producing a 1,346-bp fragment; 5CCAGGTGTT
TCGATATTGAT3 and 5GCCTGTGTGGTGTTCGAATC3 for CB21-4, pro-
ducing a 503-bp fragment; 5CTGGTTACATTTTCGCCTATCA3 and 5CCT
AGTCCAAACTAGGGCTTGA3, for cS10-A6, producing a 341-bp fragment;
5ATTTGTGTTTCCGAGCAGGT3 and 5TCGCCGAAGAGTTGACATAG
3, for GRA6, producing a 351-bp fragment; and 5GGCTATTCGGCAAACA
ACAC3 and 5GCAATCCAGTGAGTCACCAA3 for L363, producing a 505-
bp fragment. The PCR products and the restriction fragments were fractionated
in either 6% acrylamide or a 2.5% agarose gel.
DNA sequencing and analysis. The codifying region of the SAG1, SAG2 and
SAG3 genes of P-Br were amplified. The amplification products were cloned into
PCR4-Topo vector (Invitrogen, Carlsbad, Calif.) and were sequenced by using
the DYEnamic Et Dye Terminator Cycle Sequencing kit for MegaBace (Amer-
shan Pharmacia Biotech, Little Chalfont, Buckinghamshire, United Kingdom).
We performed a homology search by using the National Center for Biotechnol-
ogy Information gene bank database.
Experimental infections. The P-Br strain of T. gondii, isolated from a dog in
Brazil (28), and the ME-49 strain of T. gondii, isolated from a sheep (36), were
used to infect mice in the experiments described in this study. Cysts were har-
vested from Swiss mice that had been inoculated 2 months beforehand with
approximately 10 cysts, by the oral route. The mice were sacrificed by cervical
dislocation; the brains were removed and homogenized in 1 ml of phosphate-
buffered saline, pH 7.2. For experimental infections, mice received 4, 20, or 100
cysts in a volume of 0.2 ml orally.
Splenocyte cultures. Mice infected with either the T. gondii ME-49 or P-Br
strain were sacrificed on the 7th and 15th days postinfection and had their
spleens removed. For controls we used spleens from uninfected mice (day 0).
Suspensions of splenocytes were washed in RPMI medium and were treated for
2 min with lysing buffer (9 volumes of 0.16 M NH4Cl and 1 volumes of 0.17 M
Tris-HCl, pH 7.5). The erythrocyte-free cells were then washed three times and
were adjusted to 5  106 cells/ml in RPMI supplemented with 10% heat-
inactivated fetal calf serum. The cell suspension was distributed (100 l/well) in
a 24-well tissue culture plate and was cultured with RPMI medium alone, for 48 h
and 72 h at 37°C in 5% CO2. The supernatants were subsequently collected for
cytokine and nitrite measurements.
Nitrite concentrations. The nitrite concentration in the cell culture superna-
tants were measured by using the Griess assay (19). The levels of nitrite in the
culture supernatants after 48 h was assayed in a 96-well microplate by mixing 0.1
ml of culture supernatant with 0.1 ml of Griess reagent. The plates were read for
absorbance at 490 nm after 10-min incubations, and the nitrite concentrations
were determined in reference to a standard curve of 1 to 500 M NaNO2.
Cytokine measurement. IL-10 and TNF- were quantified in 48-h superna-
tants of the spleen cells by using the Duo Set kit (R&D Systems, Minneapolis,
Minn.). IL-12 (p70) and IFN- were quantified in 72-h supernatants of the spleen
cells by using the enzyme-linked immunosorbent assay DuoSet kit (Genzyme,
Cambridge, Mass.). The development was made with streptavidin-peroxidase
conjugate. The plates were read at 405 nm and concentration calculated in
reference to a standard curve employing respective recombinant cytokines.
Histopathology and immunocytochemistry. A histological examination was
carried out in the brain and intestine of mice. The brain was evaluated 45 days
after infection. The intestine was evaluated 7 days postinfection. Following
processing, the samples were set in paraffin and were sectioned in slices of 4-m
width. The material was stained with hematoxylin-eosin, subjected to immuno-
cytochemical analysis, and examined under a light microscope. For immunocy-
tochemistry, deparaffinized sections were incubated for 30 min at 37°C in 2%
unlabeled sheep serum to reduce nonspecific binding and were then incubated in
polyclonal rabbit antibody against whole parasites of strain P-Br of T. gondii at
4°C overnight. Secondary biotinylated antibodies were sheep anti-rabbit antibod-
ies. The sensitivity was improved with the avidin-biotin technique (ABC kit,
PK-4000; Vector Laboratories, Inc., Burlingame, Calif.). The reaction was visu-
alized by incubating the section with 3,3-diaminobenzidine tetrahydrochloride
(Amresco, Solon, Ohio) for 5 min. Control slides were incubated in the unrelated
rabbit serum. The slides were studied with an Olympus microscope and were
photographed with Kodak film (100 ASA).
Statistical analysis. The statistical significance of differences between survival
curves in 15, 30, and 45 days postinfection, as well as cyst numbers, was deter-
mined by the Kruskal-Wallis nonparametric test. The intensity of inflammatory
reaction in the brain or small intestine, as well as cytokine and nitrite levels in the
supernatants from cultures of splenocyte obtained from different groups of mice,
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was determined by analysis of variance. For all statistical tests mentioned above,
the difference was considered statistically significant when P was  0.05.
RESULTS
P-Br is a recombinant (type I-III) strain of T. gondii. To
identify the alleles carried by different genes or regions present
in the genome of P-Br strain of T. gondii, different restriction
endonucleases defined in Table 1 were used to digest B1,
cS10-A6, GRA6, L363, ROP1, SAG1, SAG2, and SAG3 ampli-
cons. Strains RH and P-Br exhibited identical restriction pat-
terns for B1, CB21-4, ROP1, and SAG1, and this was different
from ME-49/PTG (type II) and VEG/CTG (type III) strains.
These findings indicate that P-Br possesses a type I haplotype
for several loci. In contrast, for cS10-A6, GRA6, and SAG3,
strain P-Br displayed a genotype identical to that of the CTG
strain and differed from RH and PTG strains, indicating that
P-Br has haplotype III at these loci. Interestingly, for L363 and
SAG2 loci, the P-Br strain has a mixture of haplotypes seen in
type I and III strains. In the case of SAG2, we used four dif-
ferent restriction enzymes, since HhaI, HinfI, and TaqI yielded
fragments identical to type 1, whereas digestion with Sau3AI
generated a type III allele. For the cB21-4 microsatellite mark-
er, the RFLP generated a unique haplotype. The sequencing of
the coding region from the SAG1, SAG2, and SAG3 genes
showed that nucleotide sequences from P-Br strain presented
higher to lower homology to genes from RH (type I), VEG
(type III), and ME-49 (type II) (Fig. 1).
Distinct biological behavior of strain P-Br of T. gondii in
isogenic mouse strains. Peroral infection of BALB/c, C3H/He,
and C57BL/6 mice with four cysts from the P-Br strain re-
sulted, at 45 days postinfection, in 81, 9, and 76% survival,
respectively. In contrast, infection with ME-49, a well-estab-
FIG. 1. The coding region of the SAG1 (GenBank accession no. AY187278) gene from strain P-Br presented 99.9, 97, and 97% homology with
SAG1 from RH, ME-49, and VEG, respectively. The coding region of the SAG2 gene (GenBank accession no. AY187279) from P-Br presented
100, 98, and 99% homology with SAG2 from RH, ME-49, and VEG, respectively. The coding region of the SAG3 gene (GenBank accession no.
AY187280) from P-Br presented 100, 98, and 99% homology with SAG1 from RH, ME-49, and VEG, respectively. Underlined letters indicate
natural nucleotide mutations of type I, type II, and type III standard strains in relation to the sequence of the same DNA from the P-Br strain.
TABLE 1. Genotyping of SAG1, SAG2, SAG3, B1, ROP1, cB21-4, cS10-A6, GRA6, and L363 loci from T. gondii strains
Locus Endonuclease(s)
Allele type
RH (I) ME49 orPTG (II)
VEG or
CTG (III) P-Br P-Br haplotype
SAG1 HaeII 1 2 2 1 I
DdeI 1 2 2 1
SAG2 HhaI 1 2 3 1 Unique (combination of I–III)
Sau3aI 1 2 3 3
TaqI 1 2 1 1
HinfI 1 1 2 1
SAG3 NciI 1 2 3 3 III
B1 XhoI 1 2 2 1 I
PmlI 1 2 2 1
ROP1 DdeI 1 2 2 1 I
HhaI 1 2 2 1
cB21-4 (microsatellite and RFLP marker) HaeIII 1 2 3 4 Unique
cS10-A6 RsaI 1 1 2 2 III
HpyCH4IV 1 2 1 1
GRA6 MseI 1 2 3 3 III
L363 HpaII 1 2 2 1 Unique (combination of I–III)
HpyCH4IV 1 1 2 2
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lished type II strain, in BALB/c, C3H/He, and C57BL/6 mice
resulted in 87, 56, and 23% survival, respectively (Table 2; Fig.
2). Thus, strain P-Br exhibited high virulence in C3H/He and
low virulence in the BALB/c and C57BL/6 mice, whereas strain
ME-49 exhibited high virulence in C57BL/6, moderate viru-
lence in C3H/He, and low virulence in BALB/c mice.
In terms of cyst numbers and TE, the C3H/He mice showed
high susceptibility to infection with either the P-Br or ME-49
strain of T. gondii. As expected, BALB/c and C57BL/6 mice
were resistant and highly susceptible to cyst formation and TE,
when infected with the ME-49 strain. Surprisingly, the BALB/c
mice were more susceptible to cyst formation and TE than
C57BL/6 mice, when infected with the P-Br strain. It is also
known (35) that one of the main pathologies observed in
C57BL/6 mice acutely infected with ME-49 is necrosis in the
intestinal mucosa. Here, we compared the ability of the P-Br
and ME-49 strains to cause lesions in the intestinal tissues. The
results shown in Fig. 3 and Table 2 reveal that strain ME-49
but not P-Br causes intense tissue pathology in the intestinal
mucosa from C57BL/6 mice. Neither the ME-49 or P-Br strain
causes large lesions in the intestine of BALB/c or C3H/HeJ
mice.
To further confirm the reverse phenotype of the P-Br strain
in the BALB/c and C57BL/6 mice, we performed a second set
of experiments. BALB/c and C57BL/6 mice were infected with
4, 20, or 100 cysts of each parasite strain. Infection of BALB/c
mice with 4, 20, and 100 cysts of P-Br resulted in 100, 100, and
66% survival, respectively. Similar results were obtained in
terms of mortality in the C57BL/6 mice, except that only 10%
of the mice died when infected with 100 cysts of the P-Br
strain. Infection with 4, 20, and 100 cysts of the ME-49 strain
resulted in 100, 80, and 70% survival in the BALB/c mice,
respectively. In contrast, we observed 23, 0, or 0% survival in
C57BL/6 infected with 4, 20, or 100 cysts of the ME-49 strain
(Table 3). The severity of pathology (inflammation and necro-
sis) in the small intestine did correlate with the intensity of
intestinal tissue parasitism in BALB/c and C57BL/6 after per-
oral infection with 4, 20, or 100 cysts of either P-Br or ME-49.
FIG. 2. Survival of female BALB/c, C3H/He, and C57BL/6 mice after peroral infection with four cysts of either strain P-Br or ME-49 of T.
gondii. Infection with P-Br resulted in low (3 of 35 mice), high (22 of 27 mice), and high (41 in 54 mice) survival in C3H/HeJ, BALB/c and C57BL/6
mice, respectively. Infection with ME-49 resulted in low (5 of 22), moderate (9 of 16), and high (28 of 32) survival in C57BL/6, C3H/He, and
BALB/c mice, respectively. The experiment was repeated three to five times and provided similar results. The presented results are pooled from
the experiments for each parasite and mouse lineage combination. All the survivors were infected, as confirmed by the presence of cysts in the
brain. The significance of survival rate differences between lineages infected with the same strain and of differences between strains in terms of
behavior in the same mouse lineage was determined by the Kruskal-Wallis test (P  0.05) 15, 30, and 45 days postinfection. This analysis indicates
that the survival curve of C3H/He mice was statistically different from those of C57BL/6 and BALB/c mice infected with P-Br, that the survival
curve of C57BL/6 mice was statistically different from those of C3H/He and BALB/c mice infected with the ME-49 strain, and that the survival
curves of C3H/He and C57BL/6 mice were statistically significant when mice infected with P-Br and ME-49 were compared.
TABLE 2. Histopathological analysis of the CNS and small intestine of female BALB/c, C3H/HeJ, and C57BL/6 mice
after peroral infection with four cysts of strain P-Br or ME-49 of T. gondiia
Mouse type
Oral infection results for each strain used
P-Br ME-49
No. of animalsb, f
evaluated No. of cysts
c TEd SIe No. of animalsevaluated No. of cysts TE SI
BALB/c H-2d 22/27 (aA) 727 	 358 (aA)   28/32 (aA) 202 	 71 (aB)  
C3H/He H-2k 3/35 (bB) 13,925 	 2,015 (cA)   9/16 (aA) 28,141 	 15,285 (bA)  
C57BL/6 H-2b 41/54 (aA) 151 	 40.5 (bA)   5/22 (bB) 4,175 	 3,103 (bB)  
a Mice were perorally infected with four cysts of the ME-49 or P-Br strain of T. gondii. These data are pooled from three to five experiments for each mouse-parasite
combination, which yielded similar results.
b Indicates the number of survivors out of the total number of animals used in the experiment. All the survivors were infected, as confirmed by the presence of cysts
in the brain.
c The number of brain cysts and intensity of TE were evaluated at 45 days postinfection.
d Two sagittal sections from each mouse were examined and scored for pathological changes, by hematoxylin-and-eosin staining. , mild; , moderate; ,
severe; , very severe.
e The small intestine (SI) was evaluated after 7 days postinfection and was scored for pathological changes by hematoxylin-and-eosin staining.
f Different lowercase letters indicate statistically significant differences between mouse lineages infected with the same strain, while different capital letters indicate
statistically significant differences between forms of behavior of parasite strains within the same mouse lineage, as indicated by the Kruskal-Wallis test (P  0.05).
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Indeed, the intestinal mucosa of C57BL/6 presented from 5- to
15-fold more parasites when infected with the ME-49 than
when infected with the same dose of P-Br. Importantly, giv-
ing higher doses (i.e., 20 or 100 cysts) of cysts from P-Br to
BALB/c mice resulted in a dramatic increase of cysts in the
brain, at 45 days postinfection. In contrast, increasing the num-
ber of infective cysts of ME-49 and P-Br to BALB/c and
C57BL6 mice, respectively, resulted in a rather small incre-
ment of cysts in the CNS at 45 days postinfection.
Role of IL-12/IFN- axis and iNOS in early resistance to the
P-Br strain of T. gondii. IL-12 has been postulated to play a key
role in induction of Th1 responses, whereas IFN- and TNF-
are important cytokines in triggering effector mechanisms by
macrophages and nonprofessional phagocytic cells. Production
of IL-10 has also been shown to be stimulated during infection
with T. gondii and to be involved in regulating the production
of IL-12, IFN-, and TNF-. To study the ability of P-Br to
stimulate cytokine synthesis in vivo, we measured the produc-
tion of cytokines 7 and 15 days postinfection by spleen cells
from mice infected with T. gondii cultured in vitro in the ab-
sence of antigen (Fig. 4). Our experiments demonstrated high
levels of these cytokines and RNI in the supernatants of
splenocytes of BALB/c, C57BL/6, and C3H/He mice infected
with either the P-Br or ME-49 strain. Interestingly, peroral
infection with P-Br was shown to elicit earlier (7 days postin-
fection) IFN-, IL-12, IL-10, and TNF- production than did
infection with ME-49, which in most cases induced noticeable
cytokine production only by 15 days postinfection. The kinetics
of RNI produced by splenocytes was similar in mice infected
with either the P-Br or ME-49 strain. The levels of RNI and
cytokines produced by spleen cells from uninfected mice were
below the limits of sensitivity of the assays employed in our
study.
IL-12 KO, IFN- KO, and iNOS mice were infected with
four cysts of P-Br, and their survival was monitored over a
45-day period. Mortality experiments for each mouse strain
were repeated two times, and the data presented are represen-
tative of one experiment. Infection in IL-12 and IFN- KO
mice resulted in 100% mortality around 15 to 20 days postin-
fection (data not shown). Infection of iNOS KO mice resulted
in 20% survival. The survivor iNOS KO was sacrificed at 45
days postinfection and showed 4,100 cysts/brain. All C57BL/6-
infected mice survived and showed an average of 90 cysts/
brain.
MHC haplotype d is not a main determinant of mouse
resistance to the P-Br strain of T. gondii. The influence of
MHC on survival and brain cyst numbers was examined in
congenic mouse strains carrying the d haplotype. Experiments
were performed to compare survival rates and number of brain
cysts after peroral infection with the P-Br and ME-49 strains
FIG. 3. Histological changes in the ilea of C57BL/6 mice infected perorally with T. gondii. Animals were infected with 4 (A and B) or 20 (C
and D) cysts of either the ME-49 (left) or P-Br (right), and histological analyses of small intestine were performed at 7 days postinfection. The
villi clearly visible in panels B and D are almost indiscernible in panels A and C due to inflammatory infiltration and initial stages of necrosis in
mice that were infected with ME-49. Six sections of the entire length of small intestine from each mouse were examined. Five mice were used for
each group. Slides were stained with hematoxylin and eosin. Magnification, 60.
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of T. gondii. The congenic strains named C57BL/KsJ and
DBA2/J, containing MHC haplotype d, were more resistant (as
measured by survival rates and cyst numbers) to infection by
ME-49 than were the parental lineages (i.e., C57BL/6 and
DBA1/J). In contrast, the presence of MHC haplotype d in
congenic strains compared to its presence in parental strains
did not affect resistance and/or susceptibility to cyst formation
or rates of survival of acute infection in animals infected with
strain P-Br. In female BALB/c, C57BL/6, and C57BL/KsJ mice
infected with P-Br, we observed, respectively, 81, 76, and 75%
survival at 45 days postinfection. In contrast, after infection
with ME-49, we observed in female BALB/c, C57BL/6, and
C57BL/KsJ mice 87, 23, and 100% survival, respectively (Table
4; Fig. 5). Female DBA1/J (haplotype q) mice presented high
and moderate susceptibility to infection with the ME-49 and
P-Br strains, respectively, displaying 100 and 50% mortality
before 30 days postinfection (Fig. 5). Female DBA2/J mice
displayed high survival (80%) when infected with ME-49 or
P-Br. The difference between survival curves was statistically
FIG. 4. Production of IFN-, IL-10, IL-12, TNF-, and RNI by
spleen cells from BALB/c, C3H/He, and C57BL/6 mice after peroral
infection with four cysts of either the P-Br or ME-49 strain of T. gondii.
Cytokine and nitrite levels were evaluated 7 and 15 days after inocu-
lation of the parasite. The values shown are the mean of three animals




































































































































































































































































































































































































































































































































































VOL. 71, 2003 MOUSE RESISTANCE TO A RECOMBINANT STRAIN OF T. GONDII 6397
 o
n
 January 16, 2014 by W







significant only when DBA1/J and DBA2/J mice infected with
ME-49 were compared. To measure the number of cysts in the
DBA congenic strains, we used the male, which in general is
more resistant to infection with T. gondii (30). Consistent with
the results obtained from females, the male DBA1/J mouse
presented significantly higher number of cysts when infected
with the ME-49 strain (2,442 	 741) than did the DBA2/J
mouse, which presented on average 500 	 223 cysts per animal
FIG. 5. Survival of female BALB/c, C57BL/6, and C57BL/KsJ (A) and DBA1/J and DBA2/J (B) mice after peroral infection with four cysts of
either strain P-Br or ME-49 of T. gondii. Infection with P-Br resulted in high survival of BALB/c (22 of 27), C57BL/6 (41 of 54), and C57BL/KsJ (6
of 8) mice, respectively. Infection with P-Br resulted in moderate survival of DBA1/J (11 of 22) and high survival of DBA2/J (11 of 15) mice. Infection
with ME-49 resulted in low and high survival of C57BL/6 (5 of 22) and C57BL/KsJ (7 of 7) mice, as well as high survival of BALB/c (28 of 32) mice,
respectively. Infection with ME-49 resulted in high and low survival of DBA2/J (9 in 11) and DBA1/J (0 in 15) mice, respectively. All the survivors were
infected, as confirmed by the presence of cysts in the brain. The experiment was repeated three times and provided similar results. The results present-
ed are the pooled data of three experiments. The significance of survival differences between lineages infected with the same strain and of dif-
ferences between strains in terms of parasite behavior in the same mouse lineage was determined by the Kruskal-Wallis test (P  0.05) in 15, 30, and
45 days postinfection. This analysis indicate that the survival curve of C57BL/6 mice was statistically different from those of C57BL/KsJ and BALB/c
mice infected with the ME-49 strain, that the survival curve of DBA1/J mice was statistically different from that of DBA2/J mice infected with
ME-49 strain, and that the survival curves of C57BL/6 mice were statistically significant when mice infected with P-Br and ME-49 were compared.
TABLE 4. Number of cysts in the brain of BALB/c, C57BL/6, C57BL/BKsJ, DBA1/J, and DBA2/J mice after peroral infection
with four cysts of strains P-Br and ME-49 of T. gondii
Expt no. and mouse type
Results for:
Strain P-Bra Strain ME-49a
No. of animals evaluatedb,d No. of cystsc No. of animals evaluatedb No. of cystsc
Expt 1
BALB/c H-2d (female) 22/27 (aA) 727.6 	 358 (aA) 28/32 (aA) 202 	 71 (aB)
C57BL/6 H-2b (female) 41/54 (aA) 151 	 40 (bA) 5/22 (bB) 4,175 	 3,103 (bB)
C57BL/KsJ H-2d (female) 6/8 (aA) 243 	 220 (bA) 7/7 (aA) 62.5 	 17.7 (aA)
Expt 2
DBA1/J H-2q (female) 11/22 (aA) 1,525 	 740 (aA) 0/15 (bB) *e
DBA2/J H-2d (female) 11/15 (aA) 725 	 204 (aA) 9/11 (aA) 203 	 5 (aB)
a Mice were perorally infected with four cysts of the ME-49 or P-Br strain of T. gondii. These data are pooled from three to five experiments for each mouse, parasite
combination that yielded similar results.
b Indicates the number of survivors out of total number of animals used in all experiments. All the survivors were infected, as confirmed by presence of cysts in the
brain.
c The number of brain cysts was evaluated at 45 days postinfection.
d Different lowercase letters indicate statistically significant differences between mouse lineages infected with the same strain, while different capital letters indicate
statistically significant differences between forms of behavior of parasite strains within the same mouse lineage, as indicated by the Kruskal-Wallis test (P  0.05).
e *, all animal succumbed by day 45 postinfection.
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at 45 days postinfection. In DBA1/J and DBA2/J mice infected
with the P-Br strain, we observed 1,035 	 275 and 783 	 377
cysts in the brain, respectively.
DISCUSSION
T. gondii strains can be divided in three main lineages based
on various genetic markers (42). Studies with mice have shown
that infection with each of the three lineages of T. gondii
results in different outcomes: type I strains are highly virulent,
whereas type II and III strains are relatively avirulent (42).
Type I differs genetically by 1% or less from type II and type III
(27). However, the main determinants that dramatically affect
the virulence of different T. gondii strains in the host and
pathogenesis of toxoplasmosis are poorly understood.
Type II strains of T. gondii appear to be dominant in U.S.
territory and are frequently isolated from AIDS patients with
TE (27). Interestingly, different studies suggest the involve-
ment of type I and type I-III strains in the development of
ocular disease. Thus, different studies show a higher preva-
lence of type I and type III strains in Brazil (10, 42), where the
occurrence of acquired ocular toxoplasmosis is more frequent
(43). Consistently, type I was identified as responsible for a
toxoplasmosis outbreak associated with a high rate of devel-
opment of acquired ocular disease (5). In addition, a recent
study indicates a high frequency of type I as well as type I-III
recombinant isolates from ocular lesions in patients from the
United States (22). In the present report, we characterized a
natural recombinant type I-III strain of T. gondii and estab-
lished the involvement of cytokines as well as MHC haplotype
in mouse resistance and susceptibility to infection with this
particular parasite strain.
Different cytokines, such as IL-12, IFN-, and TNF-, as
well as RNI, have been shown to play an important role in
resistance to early as well as late stages of infection with T.
gondii parasites. Thus, IFN- inhibits replication of T. gondii
within macrophages and somatic cells (7) and can confer pro-
tection against lethal Toxoplasma challenge (46). The action of
IFN- appears to be only partially dependent on the produc-
tion of RNI, and other mechanisms are apparently involved
(6). In addition, the counterregulatory cytokine IL-10 has been
shown to be essential in preventing an overwhelming and lethal
immune response during acute infection with T. gondii (16).
Here we compared the ability of the ME-49 and P-Br strains
to elicit cytokine response at the initial stage of infection, in
different mouse lineages (BALB/c, C57BL/6, and C3H/He).
Our results show that both parasite strains elicited type I cy-
tokines (i.e., TNF-, IL-12, and IFN-) as well as the counter-
regulatory cytokine IL-10. In addition, both parasite strains
induced the production of high levels of RNI by spleen cells.
However, we did not observe any major difference in the ability
of ME-49 and P-Br strains to elicit cytokine production that
could explain the different behavior of the studied T. gondii
strains in the various inbred mouse lineages. Importantly, cy-
tokine production by spleen cells elicited during infection with
the P-Br strain was in most cases high by 7 days postinfection,
whereas production of cytokine by ME-49 was mainly notice-
able by day 15 postinfection. In addition, the cytokine produc-
tion elicited by P-Br was higher than that elicited by ME-49 in
all mouse lineages. To confirm the importance of these cyto-
kines in host resistance to the P-Br strains, we used the IFN-
KO, IL-12 KO, and iNOS KO mice. As previously shown for
the ME-49 strain (6, 41, 48), all the KO mice employed here
were highly susceptible to infection with the P-Br strain.
A well-known mechanism of pathogenesis and death during
acute infection of C57BL/6 mice with the ME-49 strain of T.
gondii is the inflammatory process and necrosis observed in
the small intestine (35). These pathological effects are thought
to be mediated at least in part by CD4 T lymphocytes,
TNF-, IFN-, and RNI (33, 34, 35). Despite the similar (or
even higher) cytokine and RNI levels produced in spleen cells
from mice infected with P-Br, we observed no (or very little)
pathology in the small intestine of C57BL/6 mice infected with
P-Br strain compared to that found in the intestine of mice
infected with ME-49. A possible explanation for these discrep-
ant findings would be the intensity of intestinal tissue parasit-
ism yielded during infection with each parasite strain. Indeed,
we found that infection with the ME-49 always led to a much
higher load of parasite in the small intestine. Thus, as previ-
ously postulated (34, 35), we favor the hypothesis that, even
though the immune response is actively involved in this patho-
logical process (33, 34, 35), the intensity of tissue parasitism is
also an important component for eliciting inflammation and
causing necrosis in the small intestine of C57BL/6 mice acutely
infected with T. gondii.
Inbred strains of mice markedly differ in their susceptibility
to peroral infection with T. gondii. The pattern of resistant,
intermediately resistant, and susceptible strains of mice indi-
cates that genetic regulation of resistance to peroral T. gondii
infection is polygenic (2, 37). The relative pathogenicity of T.
gondii can be influenced by route of inoculation age, gender,
genotype of the host, and life cycle stage of the parasite as well
as parasite strain (2, 30, 31). Brown and McLeod (4) reported
the importance of MHC class I genes at H-2L in the regulation
of formation of T. gondii cysts in brain of mice. The number of
cysts that form after peroral infection with T. gondii is associ-
ated with the level of parasitemia in initial infection (37).
Further, resistance to cyst formation and development of TE
has been linked in H-2d mice to the MHC class I L gene (4, 45).
Mortality is substantially greater in mice that have H-2b than in
mice possessing an H-2d background (2, 3). In addition, mor-
tality at the acute phase of infection appears to be controlled
by MHC class II genes (30).
However, most in vivo studies described above have em-
ployed parasite strains of type II lineage. A recent study (29)
shows that infection with the type II, but not type I, strain of T.
gondii elicits a CD8-lymphocyte-mediated Ld-restricted kill-
ing of parasite-infected targets. Herein, we evaluated the bio-
logical behavior in mice of a natural recombinant (type I-III)
strain of T. gondii displaying relatively low virulence in mice
and performed the experiments side by side with ME-49, which
is a standard type II strain. Interestingly, we found that, while
the C57BL/6 (H-2b) mice were highly resistant, BALB/c (H-2d)
mice were more susceptible to cyst formation and TE induced
during infection with P-Br. Furthermore, C57BL/6 mice in-
fected with the P-Br strain were resistant to the typical intes-
tinal lesions induced by infection with the ME-49 strain.
The involvement of MHC molecules (H-2b and H-2d) in host
resistance and/or susceptibility to P-Br compared to results for
the ME-49 strain of T. gondii was further investigated by using
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congenic mouse strains. These studies confirmed the impor-
tance and the lack of importance of the H-2d haplotype in
mouse resistance to cyst formation and TE elicited during
infection with the ME-49 and P-Br strains, respectively. Thus,
C57BL/KsJ and DBA2/J mice containing the H-2d haplotype
were highly resistant, compared to their progenitor strains
C57BL/6 (H-2b) and DBA1/J (H-2q) infected with ME-49. In
contrast, the resistance of C57BL/KsJ and DBA2/J was not
affected when compared to C57BL/6 and DBA1/J mouse
strains infected with the P-Br strain.
In conclusion, we showed in inbred mouse lineages that the
balance of host resistance and/or susceptibility to cyst forma-
tion and TE infection with T. gondii also depends on the
parasite strain. We demonstrated the importance of the IL-12/
IFN- axis and iNOS in host resistance to a low-virulence
recombinant strain type I-III of T. gondii. However, the differ-
ence in the ability to elicit cytokines appears not to justify the
different behavior of the type II and type I-III T. gondii strains
in inbred mice. Interestingly, our results indicate that MHC
haplotype d is not primarily involved in host resistance to cyst
formation and TE elicited during infection with T. gondii strain
type I-III and therefore differs from resistance to type II strains
(2, 4). Therefore, we believe that this study provides new in-
formation for understanding the importance of host and par-
asite genetic variability in pathogenesis and host resistance to
infection with T. gondii.
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